
Lunai Bioworks Targets Ten Defendants in Naked Short Selling Lawsuit
Lunai Bioworks has escalated its legal battle against alleged market manipulation, filing an amended complaint in Delaware naming ten defendants—including three FINRA-registered broker-dealers. The company claims these parties engaged in a coordinated naked short selling scheme that resulted in failures to deliver shares totaling over 81% of its outstanding stock.

























